Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Gains from Investment Securities (2016 - 2022)

Wave Life Sciences' Gains from Investment Securities history spans 6 years, with the latest figure at -$12.0 million for Q4 2022.

  • For Q4 2022, Gains from Investment Securities changed N/A year-over-year to -$12.0 million; the TTM value through Dec 2022 reached -$7.1 million, changed N/A, while the annual FY2022 figure was -$12000.0, 100.27% down from the prior year.
  • Gains from Investment Securities reached -$12.0 million in Q4 2022 per WVE's latest filing, down from $2.6 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.6 million in Q1 2019 to a low of -$12.0 million in Q4 2022.
  • Average Gains from Investment Securities over 3 years is -$574125.0, with a median of $28000.0 recorded in 2018.
  • Peak YoY movement for Gains from Investment Securities: crashed 172.22% in 2018, then skyrocketed 19923.08% in 2019.
  • A 3-year view of Gains from Investment Securities shows it stood at -$59000.0 in 2018, then soared by 4440.68% to $2.6 million in 2019, then crashed by 569.27% to -$12.0 million in 2022.
  • Per Business Quant, the three most recent readings for WVE's Gains from Investment Securities are -$12.0 million (Q4 2022), $2.6 million (Q3 2019), and $2.3 million (Q2 2019).